
CAS 1360540-81-3PubChem CID 56837361
Dalosirvat
Dalosirvat is under investigation in clinical trial NCT03742518 (A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia). — DrugBank
- IUPAC 名称
- 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenylbutane-1,4-dione
- 分子式
- C18H16O4
- 分子量
- 296.3 g/mol
- 精确质量
- 296.10485899 Da
- XLogP3
- 1.8
- 拓扑极性表面积
- 52.6 Ų
- 氢键供体
- 0
- 氢键受体
- 4
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
Dalosirvat [INN]Dalosirvat [USAN]SM-04554QX6T87A52IUNII-QX6T87A52Icompound 1 [WO2012024404A1]1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-phenyl-butane-1,4-dione1,4-Butanedione, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenyl-
另有 16 个已报告名称
1-(2,3-Dihydro-benzo(1,4)dioxin-6-yl)-4-phenyl-butane-1,4-dionecompound 1 (WO2012024404A1)RefChem:130821Wnt pathway activator 11-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenylbutane-1,4-dioneDalosirvat [USAN:INN]AOCDRSSVFUCURK-UHFFFAOYSA-NUS10314832, Compound 1GLXC-20808GLXC-26868EX-A3071WHO 11422AC-31958MS-24243DB-179802HY-135516
外部数据库标识符
- ChEMBL:CHEMBL4650339
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。